Membership 2018-02-14T12:19:33+00:00

DTA Membership

Digital Therapeutics Alliance: An Industry Collaboration

WORKING TO IMPROVE PATIENT OUTCOMES

DTA member organizations are dedicated to:

  • Encouraging data-driven integration and utilization of digital therapeutics across the healthcare industry
  • Engaging patients and enabling healthcare providers to intelligently manage and expand the delivery and quality of patient care
  • Optimizing clinical treatment pathways, enhancing patient outcomes, and increasing overall healthcare value
  • Educating patients, providers, payers, and other healthcare industry stakeholders on the value and improved health outcomes delivered through digital therapeutics

DTA Membership

DTA MEMBER ORGANIZATIONS RECEIVE NUMEROUS BENEFITS, INCLUDING:

  • Gaining access to and engaging with leading digital therapeutic companies
  • Guiding the development of the evolving digital therapeutics industry
  • Gaining a privileged view into the design of foundational industry frameworks and best practices
  • Developing a streamlined pathway to market for digital therapeutics
  • Expanding repositories of industry data and insights
  • Driving clinical, organizational, and financial integration of digital therapeutics into mainstream healthcare
Note: DTA Members must be companies and organizations active in the digital therapeutics industry and in alignment with DTA’s mission. Digital therapeutic companies applying for membership must demonstrate additional clinical research, product development, quality system, and regulatory engagement criteria as specified in the membership application.
Membership applications will be accepted on a rolling basis. Alliance leadership will review all applications and welcome the first group of new members in late February 2018. Questions regarding DTA membership may be sent to membership@dtxalliance.org.

Strategic Advisors

Strategic Advisors are individual thought leaders in the healthcare industry who engage with DTA Leadership and offer insight on the development of Alliance goals and initiatives. These individuals are not directly affiliated with a DTA Member company and serve one-year terms.

Note: Strategic Advisor applications will be accepted on a rolling basis. Alliance Leadership will review applications and welcome the first group of Strategic Advisors in February 2018. Questions may be sent to info@dtxalliance.org.

Alliance Overview

The Digital Therapeutics Alliance is a trade association that represents the healthcare industry’s leading manufacturers of clinically-validated digital therapeutics.

DTA’s mission is to broaden the understanding, adoption, and integration of digital therapeutics into mainstream healthcare through education, advocacy, and research.

PRIORITIES

DTA’s mission is to broaden the understanding, adoption, and integration of digital therapeutics into mainstream healthcare through education, advocacy, and research.

The Alliance will accomplish this through building networks of diverse stakeholders, mapping the evolving DTx industry landscape, assessing the value and impact of digital therapeutics in clinical practice, generating insights on successful models and outcomes, and encouraging broad collaboration across the healthcare industry.


ORGANIZATION STRUCTURE

DTA’s organizational structure ensures the ongoing integrity of our work while enabling expansive member visibility and engagement. The Alliance’s mission and priority initiatives are developed by senior leaders from digital therapeutic companies. DTx member companies must meet key clinical research, product development, quality system, and regulatory engagement qualification criteria.

The Alliance’s Membership Board is composed of representatives from each DTA member organization and oversees progress being made on priority issues. DTA Working Groups, open to participation by all members, are responsible for developing target deliverables.

MEMBERS

DTA members include digital therapeutic companies, healthcare providers, payers, academic institutions, patient groups, investors, technology and data organizations, pharmaceutical manufacturers, in addition to other organizations actively engaged in the digital therapeutics industry.


INTERNATIONAL ENGAGEMENT

DTA is headquartered in the United States and maintains an international focus on the DTx industry.


INDUSTRY ENGAGEMENT

The Alliance recognizes the efforts of other healthcare organizations engaged in the evidence-driven advancement of digital therapeutics to improve patient outcomes. DTA is committed to supporting the ongoing work of organizations aligned with the Alliance’s mission.


FUNDING

The Alliance is funded through annual membership dues.

DIGITAL THERAPEUTICS

Digital therapeutics are clinically-validated solutions that may be used as standalone direct treatments or in association with other treatments to improve the overall quality, cohesion, outcomes, and value of healthcare delivery. Digital therapeutics demonstrate safety and efficacy in randomized control trials, receive regulatory clearance when used as a medical device, integrate into clinical practice, and are tailored to patients’ clinical needs, goals, and lifestyles. These solutions consist of patient-facing treatments, clinical assessment and outcomes tracking tools, clinician monitoring dashboards, and HIPAA-compliant data storage.

Stay Up To Date

SIGN UP FOR DTA NEWS & UPDATES

Sign Up Now